Assist Prof Dr. Juan Yakisich - Cancer Cell Biology - Best Researcher Award

Hampton University - United States

AUTHOR PROFILE

EARLY ACADEMIC PURSUITS

Juan Sebastian Yakisich, MD, PhD, pursued an interdisciplinary biomedical research path, obtaining his doctoral education at the esteemed Karolinska Institute in Europe, one of the largest and most prestigious medical universities. His early academic pursuits laid the foundation for his expertise in cell & molecular biology, cancer biology & molecular oncology, and pharmacology.

PROFESSIONAL ENDEAVORS

Following his doctoral education, Dr. Yakisich undertook postdoctoral training at the Department of Molecular and Cellular Medicine, Texas A&M University, College Station, TX. His professional journey also included a highly competitive and prestigious research grant from the Swedish Research Council, leading to four additional years as a project leader at the Department of Clinical Neuroscience, Karolinska Institute.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER CELL BIOLOGY

Dr. Yakisich possesses a comprehensive background in cancer cell biology and pharmacology, specializing in cellular and molecular biology, anticancer drug screening, and cancer stem cell biology. His significant contributions include the development of a groundbreaking cancer stem cell model (The stemness phenotype model) applicable to various cancer types, with substantial clinical implications. Additionally, he pioneered effective strategies for anticancer drug screening, addressing limitations in existing programs.

IMPACT AND INFLUENCE

As an oncology researcher, Dr. Yakisich has made a substantial impact, contributing to the understanding and treatment of various cancers, including brain tumors, cervical, lung, and breast cancers. His work has not only shaped research directions but has practical applications in clinical settings, improving the screening of oncology markers and enhancing drug delivery into cancer cells.

ACADEMIC CITES

Dr. Yakisich's academic achievements are reflected in his publication record, including over 60 peer-reviewed original articles and reviews in international leading journals. He has served as a grant and postdoctoral fellowship reviewer for NASA and held editorial and associate board memberships in international peer-reviewed journals such as Frontiers in Pharmacology.

LEGACY AND FUTURE CONTRIBUTIONS HIGHLIGHT

In his tenure at Hampton University, Dr. Yakisich has continued to contribute significantly, publishing over twenty-five peer-reviewed articles and three book chapters. His commitment to education is evident through mentoring and training Master's, PhD, undergraduate, and high school students in multiple countries. Dr. Yakisich emphasizes a commitment to mentor and train underrepresented minorities in basic and translational research, leaving a lasting legacy of diversity and inclusion.

FUTURE CONTRIBUTIONS

Looking ahead, Dr. Yakisich is actively engaged in the development of aptamer-based biomedical tools for identifying oncology markers, pathogen detection and elimination, and drug delivery into cancer cells. His dedication to mentoring and training underscores a commitment to advancing scientific knowledge and fostering the next generation of researchers, ensuring a continued impact on the field of biomedical research.